CRA–13  synthetic, CB1 & CB2 agonist

 

Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration.            (abst – 2007)  http://www.ncbi.nlm.nih.gov/pubmed/17630726?dopt=Abstract

 

Cannabinoid Receptor Agonist 13, a Novel Cannabinoid Agonist: First in Human Pharmacokinetics and Safety (full – 2009)  http://dmd.aspetjournals.org/content/37/4/827.full

 

Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism. (abst – 2009)  http://www.ncbi.nlm.nih.gov/pubmed/19280324

 

Share a link for